New approach aims to stop HIV and opioid relapse after jail release

NCT ID NCT06854029

Summary

This study aims to prevent HIV infections and help manage opioid addiction for people transitioning from jail back to the community. Researchers will test whether long-acting injection treatments work better than daily pills at keeping people on their medications. The study involves 300 adults who are HIV-negative, have opioid use disorder, and are scheduled for release from jail within 120 days.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University Medical System

    Durham, North Carolina, 27710, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.